HUSA, Petr, Marián OLTMAN, Ljubomir IVANOVSKI, Vratislav ŘEHÁK, Mehmed GRIBAJCEVIC, Diethelm MESSINGER, Andreas TIETZ and Petr URBÁNEK. The efficacy of peginterferon alfa-2a (40 kD) in treatment-experinced patients with genotype 1 HCV: results from an opel-label, expanded access programme in Eastern Europe. In Hepatitis C 3rd International Conference The third decade ad beyond. 2009. |
Other formats:
BibTeX
LaTeX
RIS
@proceedings{840089, author = {Husa, Petr and Oltman, Marián and Ivanovski, Ljubomir and Řehák, Vratislav and Gribajcevic, Mehmed and Messinger, Diethelm and Tietz, Andreas and Urbánek, Petr}, booktitle = {Hepatitis C 3rd International Conference The third decade ad beyond.}, language = {eng}, title = {The efficacy of peginterferon alfa-2a (40 kD) in treatment-experinced patients with genotype 1 HCV: results from an opel-label, expanded access programme in Eastern Europe.}, year = {2009} }
TY - CONF ID - 840089 AU - Husa, Petr - Oltman, Marián - Ivanovski, Ljubomir - Řehák, Vratislav - Gribajcevic, Mehmed - Messinger, Diethelm - Tietz, Andreas - Urbánek, Petr PY - 2009 TI - The efficacy of peginterferon alfa-2a (40 kD) in treatment-experinced patients with genotype 1 HCV: results from an opel-label, expanded access programme in Eastern Europe. ER -
HUSA, Petr, Marián OLTMAN, Ljubomir IVANOVSKI, Vratislav ŘEHÁK, Mehmed GRIBAJCEVIC, Diethelm MESSINGER, Andreas TIETZ and Petr URBÁNEK. The efficacy of peginterferon alfa-2a (40 kD) in treatment-experinced patients with genotype 1 HCV: results from an opel-label, expanded access programme in Eastern Europe. In \textit{Hepatitis C 3rd International Conference The third decade ad beyond.}. 2009.
|